Danny Rischin, MD of Peter MacCallum Cancer Centre @PeterMacCC discusses the phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma.
Read here:Â https://meetinglibrary.asco.org/record/185846/abstract
Danny Rischin, MD on Phase II Study of Cemiplimab: Durability of Response @PeterMacCC
